All Internal Medicine principal investigators of interventional clinical trials are required to complete one of several training opportunities in the oversight and management of clinical trials before Dec. 31, 2018
Lisa Cannon Albright co-wrote a paper that looks at a new genealogy resource created with the VHA to show the potential of linking genealogy to patient data for investigating genetic...
An article co-authored by Adam Gordon, MD (Epidemiology) has been accepted for publication and looks at using traditional policy analytics scholarship to explain how opioid-related policies have evolved in the...
Congratulations to Bellamkonda Kishore, MD; Marcus Pezzolesi, PhD; Nirupama Ramkumar, MD; and Harry Senkjian, MD who have been recognized in the areas of medical advancement and research.
Congratulations to Bellamkonda Kishore, MD; Marcus Pezzolesi, PhD; Nirupama Ramkumar, MD; and Harry Senkjian, MD who have been recognized in the areas of medical advancement and research.
On Rheumatology Advisor, Karla Miller, MD (Rheumatology) co-author of a recent study on swallowing disorders offers up a clinician's perspective on dysphagia in RA.
Mark Supiano, MD (Geriatrics) said, "what is good for the heart is good for the brain," in reference to a study that found lowering blood pressure has demonstrated to lower...
On Rheumatology Advisor, Karla Miller, MD (Rheumatology) co-author of a recent study on swallowing disorders offers up a clinician's perspective on dysphagia in RA.
Jeffrey Botkin, MD (General Internal Medicine) who co-wrote a consensus study report on sharing research results with participants asks--if you give your DNA and tissues to science, should you get...
Robert Pendleton, MD (General Internal Medicine) explains that patient-facing transparency efforts in healthcare are still in the early stages, but awareness in increasing.
Robert Pendleton, MD (General Internal Medicine) explains that patient-facing transparency efforts in healthcare are still in the early stages, but awareness in increasing.
Kathleen Cooney, MD (Oncology) concludes that in the context of patient care, the increasing number of Germline mutations may have the potential to guide therapy in patients with renal cell...
Kathleen Cooney, MD (Oncology) concludes that in the context of patient care, the increasing number of Germline mutations may have the potential to guide therapy in patients with renal cell...
